Leaflet VARIVAX powder and solvent for injection suspension
Indicated for: prevention of varicella
Route of administration: injectable
Substance: live attenuated chickenpox vaccine (vaccine)
ATC: J07BK01 (Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Do not use this medicine during pregnancy.
Avoid live vaccines during treatment if contraindicated.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The live attenuated varicella vaccine is used to prevent chickenpox, a highly contagious viral disease caused by the varicella-zoster virus (VZV). The vaccine contains a weakened form of the virus, which stimulates the immune system to produce antibodies against VZV, providing long-term protection against infection.
The vaccine is administered subcutaneously, usually in two doses, with the first dose given at 12-15 months of age and the second between 4 and 6 years. It is recommended for both children and adults who have not had chickenpox or been previously vaccinated.
Common side effects include redness, pain, or swelling at the injection site, mild fever, and rashes. In rare cases, severe allergic reactions or neurological complications may occur.
The live attenuated varicella vaccine is an effective preventive measure, helping to reduce the incidence of chickenpox and its associated complications, such as secondary bacterial infections and viral pneumonia.
General data about VARIVAX
- Substance: live attenuated chickenpox vaccine
- Date of latest medicines list: 01-06-2026
- Product code: W66309005
- Pharmaceutical form: powder and solvent for injection suspension
- Quantity: 1
- Product type: Original
- Price: 211.75 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for live attenuated chickenpox vaccine
Compensation lists for VARIVAX Merck Sharp & Dohme
E2 - Sublist E - section E2 with 100% discount from the reference price
Price
Copayment
Patient
211.75 RON
211.75 RON
0.00 RON